NEW YORK (TheStreet) -- CHANGE IN RATINGS
Assurant AIZ was downgraded at Bank of America/Merrill Lynch to Underperform. $45 price target. Company could fall short of consensus earnings expectations, BofA/Merrill said. Avon AVP was downgraded at Caris & Co. from Above Average to Average. Estimates were also slashed, and the dividend may come into question, Caris said. Chesapeake Energy CHK was downgraded at Robert Baird from Outperform to Neutral. $22 price target. Ramp in liquids appears materially impaired, Baird said. ConocoPhillips COP was downgraded at BofA/Merrill to Underperform. Valuation call, based on a $63 price target, Bank of America/Merrill said. Demand Media DMD was upgraded to Hold at TheStreet Ratings. Endo Pharmaceuticals ENDP was downgraded at Cantor Fitzgerald to Hold. $39 price target. Company is still recovering from a supply disruption and has the potential Lidoderm settlement looming, Cantor said. EQT EQT was downgraded at Brean Murray to Hold. Stock is already pricing in the potential IPO of its MLP, Brean Murray said. Edwards Lifesciences EW was upgraded at Wells Fargo to Outperform. Sapien expectations are more reasonable and the product should see higher reimbursement rates. Fiserv FISV was downgraded at DA Davidson to Neutral. Valuation call, based on a $75 price target, DA Davidson said. Flextronics FLEX was upgraded at Bank of America/Merrill Lynch. $7.50 price target. Company is realizing higher margins. Genworth Financial GNW was upgraded at BofA/Merrill to Neutral. Management change is a potential positive for the company, BofA/Merrill Lynch. $8 price target. GNC Acquisition Holdings GNC was initiated with a Hold rating at TheStreet Ratings. Herbalife HLF was upgraded at Auriga USA to Buy. $68 price target. 20% pullback has created a buying opportunity, Auriga said. Heartland Payment HPY was downgraded at Wells Fargo to Market Perform. Valuation call, even though estimates are moving higher, Wells Fargo said. Kansas City Southern KSU was downgraded at BMO Capital to Underperform. Valuation call, based on a $68 price target, BMO Capital said. Regal Entertainment RGC was upgraded at Stifel Nicolaus from Hold to Buy. $17 price target. Company fundamentals are improving, Stifel Nicolaus said. TripAdvisor TRIP was upgraded at Capstone from Sell to Hold. International business is driving growth. TripAdvisor was upgraded at BofA/Merrill from Neutral to Buy. $53 price target. Estimates also boosted, given the company's secular growth drivers, BofA/Merrill said. Ubiquiti Networks UBNT was downgraded at Wunderlich from Buy to Hold. $35 price target. Company is investing more in future growth, which could cap near-term margins, Wunderlich said. Varian Medical VAR was upgraded at Barrington from Market Perform to Outperform. Radiation treatment should continue to gain traction, especially overseas, Barrington said. Whiting Petroleum WLL was initiated with an Outperform rating at Barrington. $69 price target. Company has an attractive reserve base, Barrington said. Wolverine World Wide WWW was upgraded at Jefferies to Buy from Hold. $49 price target. Acquisition is a game-changer, Jefferies said.Stock Comments / EPS Changes
Arch Coal ACI numbers were lowered at Jefferies. Shares are now seen reaching $18. Estimates also lowered on a tough environment, Jefferies said. Buy rating. Arch Coal numbers were reduced at Credit Suisse. Shares are now seen reaching $11. Estimates were also cut, given lower demand, Credit Suisse said. Neutral rating. Archer Daniels Midland ADM numbers were raised at BMO. Shares are now seen reaching $36. Estimates were also increased as new operating team creates smoother transition to improving fundamentals, BMO said. Outperform rating. Arthur J. Gallagher AJG numbers were boosted at Keefe, Bruyette & Woods. Shares are now seen reaching $37. Estimates were also increased, given better brokerage and risk management trends, KBW said. Market Perform rating. Allot Communications ALLT price target was raised at Jefferies. Shares are now seen reaching $28. Strong first-quarter results, Jefferies said. Hold rating. Anadarko Petroleum APC estimates were raised at Citigroup through 2013. Better-than-expected first-quarter results. Buy rating and $115 price target, Citi said. Anadarko APC estimates, price target raised at Credit Suisse. Shares are now seen reaching $92. Estimates were also increased, given higher upstream results, Credit Suisse said. Neutral rating. Avon estimates, price target were lowered at BMO Capital. Shares are now seen reaching $23. Estimates were also reduced, given lower realized margins, BMO Capital said. Outperform rating. Avon estimates were lowered at UBS through 2013 on uncompetitive rep compensation. Neutral rating and $23 price target. Biogen Idec BIIB estimates were increased at Morgan Stanley through 2014. Tysabri progress is encouraging, Morgan Stanley said. Overweight rating and $140 price target. Biogen Idec numbers were raised at Jefferies. Shares are now seen reaching $154. Estimates were also raised on strong underlying dynamics, Jefferies said. Buy rating. Broadcom BRCM estimates, price target were reduced at Nomura. Estimates were cut through 2013. Netlogic is not contributing as much as expected, Nomura said. Buy rating and new $42 price target. Broadcom estimates, price target were raised at BMO Capital. Shares are now seen reaching $44. Estimates were also increased, given higher core growth. Outperform rating. Cavium CAVM numbers were lowered at Jefferies. Shares are now seen reaching $37. Estimates were also lowered on guidance miss, Jefferies said. Buy rating. CBOE CBOE estimates, target were reduced at Credit Suisse. Estimates were cut through 2014. Trading volumes are declining, Credit Suisse said. Neutral rating and new $27 price target. CBOE estimates were reduced at Citigroup through 2013. RPC declines, but market share increases, Citi said. Neutral rating and $26 price target. CBS CBS estimates, price target were raised at Morgan Stanley. Shares are now seen reaching $38. Estimates were also increased, given higher licensing fees. Overweight rating. CBS numbers were raised at UBS. Shares are now seen reaching $37. Estimates were also increased as EPS momentum continues, UBS said. Buy rating. Chesapeake Energy numbers were cut at UBS. Shares are now seen reaching $20. Estimates were also lowered on first-quarter miss, UBS said. Neutral rating. Amdocs DOX price target was raised at Oppenheimer. Shares are now seen reaching $36. Emerging markets and strength in Europe outweigh pause at AT&T T , Oppenheimer said. Outperform rating. Emerson EMR estimates, price target were cut at Credit Suisse. Shares are now seen reaching $53. Estimates were also reduced, given lower realized margins, Credit Suisse said. Outperform rating. Family Dollar FDO numbers were boosted at Morgan Stanley. Shares are now seen reaching $77. Estimates were also increased, given higher expected cigarette sales. Overweight rating. FMC FMC estimates, price target were increased at Credit Suisse. Estimates were increased through 2013. Company is seeing higher margins and currency tailwinds, Credit Suisse said. Outperform rating and new $120 price target. FMC price target was raised at Jefferies to $125. Solid first quarter with conservative outlook, Jefferies said. Buy rating. Jacobs Engineering JEC numbers were cut at BMO Capital. Shares are now seen reaching $50. Estimates were also lowered on weak pricing improvement and delayed project decisions, BMO said. Outperform rating. Masco MAS estimates, price target were increased at JP Morgan. Estimates were boosted through 2013. Company is seeing higher installation gains, JP Morgan said. Underweight rating and new $12 price target. Myriad Genetics MYGN numbers were raised at Oppenheimer. Shares are now seen reaching $29. Estimates were also raised on another solid beat and raise, Oppenheimer said. Perform rating. OpenTable OPEN price target was lowered at Oppenheimer to $46. Outlook reflects international challenges, Oppenheimer said. Perform rating. Sirius XM SIRI estimates were increased at Morgan Stanley through 2013. Company raised its guidance, Morgan Stanley said. Equal-weight rating and $2.40 price target. Ubiquiti Networks UBNT numbers were raised at UBS. Shares are now seen reaching $40. Estimates were also increased as new products deliver strong performance, UBS said. Buy rating. Wisconsin Energy WEC numbers weren raised at BMO Capital. Shares are now seen reaching $38. Estimates were also increased on recovery of fuel costs for power generation and lower O&M costs, BMO said. Market Perform rating. Wynn Resorts WYNN price target was raised at Citigroup to $150. Cotai land concession officially approved, Citi said. Neutral rating. >To submit a news tip, email: tips@thestreet.com.
READERS ALSO LIKE:
Follow TheStreet on Twitter and become a fan on Facebook.
